Anne’s expertise covers both competition and distribution law, as well as pharmaceutical law.
Prior to joining HOYNG ROKH MONEGIER in 2017, Anne was a partner in a pharmaceutical law boutique firm. Previously, she worked several years for one of the largest French law firms in the Competition and European law team.
For over 20 years, she has been advising major pharmaceutical and biotech companies on competition law and regulatory matters related to pharmaceuticals, biologicals, medical devices, food supplements and cosmetics.
Anne advises clients at each step of their product’s life, from R&D to withdrawals. In parallel, she also handles all regulatory matters: advertising, communication on social media, transparency, patient support programs.
Anne assists originator companies, especially for advanced therapy medicines, in all aspects of their market access strategy: compassionate use, transition to MA, reimbursement strategy, pricing negotiations.
Her extensive expertise in competition matters includes the development and management of supply chain management schemes, life-cycle management, the adaptation of the commercial strategy of originator companies when facing generics entry, and the implementation of selective distribution networks.